Navigation Links
PAREXEL International Reports Fourth Quarter And Fiscal Year 2014 Results
Date:8/6/2014

span class="prnews_span">31.3%33.7%27.9%25.9%(a) Adjustments for legal settlements and acquisition and integration related charges, including the revaluation of HERON earn-out contingent consideration liability(b) Decrease in facility-related charges associated with restructuring plans(c) Recovery from final bankruptcy settlement on previously impaired investment(d) Tax effect on non-GAAP adjustments, and a $4.3 million adjustment due to reserve release(e) Adjustment for legal settlements and acquisition and integration related charges(f) Adjustment includes $0.4 million gain on facility sale previously impaired and $0.1 million in accelerated amortization of deferred financing fees related to credit facility modification(g) Tax effect on non-GAAP adjustments; a tax expense for one-time adjustments to deferred tax assets, a net $2.7 million expense due to changes in interest, penalties and a valuation allowance in a foreign jurisdiction, and a $2.6 million adjustment due to state valuation allowance release PAREXEL International CorporationSegment Information(Unaudited)Three Months EndedThree Months Ended(in thousands)June 30, 2014June 30, 2013Clinical Research Services (CRS)Service revenue $
385,604
$
343,435
% of total service revenue75.5%74.2%Gross profit$
24,198
$
96,385
Gross margin % of service revenue32.2%28.1%PAREXEL Consulting Services (PC)Service revenue$
55,235
$
54,288
% of total service revenue10
'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. PAREXEL Issues Updated Operational and Financial Information
2. PAREXEL International To Present At JP Morgan Healthcare Conference
3. PAREXEL International to Present at Jefferies Global Healthcare Conference
4. PAREXEL International To Present At Goldman Sachs Emerging Growth Conference
5. PAREXEL International Reports First Quarter Fiscal Year 2014 Results
6. Biotech Services Take Advantage of Technological Revolution through Innovations - Research Report on Life Technologies, PerkinElmer, PAREXEL, Genomic Health, and Bio-Reference
7. PAREXEL International Announces Acquisition of HERON Group LTD, A Leading Commercialization Consultancy
8. PAREXEL International Reports Third Quarter Fiscal Year 2013 Results
9. PAREXEL Announces Date of Third Quarter Fiscal Year 2013 Earnings Release and Conference Call
10. PAREXEL International to Present at Morningstar Conference
11. PAREXEL International Reports First Quarter Fiscal Year 2013 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/11/2014)... a one atom thick sheet of carbon, can be ... form of graphene that could have a significant impact ... paint, it could provide an ultra-strong, non-corrosive coating for ... oxide solutions can be used to paint various surfaces ... After a simple chemical treatment, the resulting coatings behave ...
(Date:9/11/2014)... PA (PRWEB) September 11, 2014 ... conferee registration is now open for Pittcon ... for laboratory science. The event will be held ... Center, New Orleans, Louisiana. , The discounted ... 20, 2015. ($350 after 2/20/2015). This affordable price ...
(Date:9/11/2014)... - Portage Biotech Inc. ("Portage" or "the Company") (OTC: ... intends to conduct a Private Placement to raise ... preclinical development activities and financial commitments to Biohaven ... Company is proposing to complete a non-brokered offering ... a price of US$0.10 per Share, for gross ...
(Date:9/11/2014)... Awarded annually by Germany’s Design Zentrum Nordrhein-Westfalen, the ... label for excellent design. METTLER TOLEDO is extremely ... Dot award in recognition of high design ... , The Quantos Handheld Powder Dispenser (HPD) ... applications involving free-flowing powders. Forget the delicacy and ...
Breaking Biology Technology:Graphene paints a corrosion-free future 2Conferee Registration Opens for Pittcon 2015; Housing & Travel Open for Reservations 2Portage Announces Proposed Private Placement 2Portage Announces Proposed Private Placement 3Portage Announces Proposed Private Placement 4METTLER TOLEDO Handheld Powder Receives Red Dot Award for Product Design 2
... 16 Monogram,Biosciences, Inc. (Nasdaq: MGRM ) ... of the company,s HIV tropism assay were presented ... Drug Resistance Workshop,in Sitges, Spain. Trofile was introduced ... in class CCR5 antagonist, in,August 2007. Recent enhancements ...
... /PRNewswire-FirstCall/ - ProMetic Life Sciences Inc.,(TSX: PLI) ... compound in clinical trial in patients with ... the European Hematology Association,held in Copenhagen, Denmark ... Director R&D, Biology, presented data on,PBI-1402 in ...
... Inc. (Nasdaq: ALXN ) today announced that ... of Alexion,Pharmaceuticals, will present at the William Blair ... a.m., local time (10:10 a.m., eastern) on,Thursday, June ... Sinha,s remarks will be available live. You can,access ...
Cached Biology Technology:Sensitivity Enhancements to Monogram's Trofile(TM) Assay Demonstrate Improved Power to Select Patients for CCR5 Antagonist Therapy 2Sensitivity Enhancements to Monogram's Trofile(TM) Assay Demonstrate Improved Power to Select Patients for CCR5 Antagonist Therapy 3Sensitivity Enhancements to Monogram's Trofile(TM) Assay Demonstrate Improved Power to Select Patients for CCR5 Antagonist Therapy 4Sensitivity Enhancements to Monogram's Trofile(TM) Assay Demonstrate Improved Power to Select Patients for CCR5 Antagonist Therapy 5Sensitivity Enhancements to Monogram's Trofile(TM) Assay Demonstrate Improved Power to Select Patients for CCR5 Antagonist Therapy 6Positive clinical data for PBI-1402 presented at the Annual Congress of the European Hematology Association 2Positive clinical data for PBI-1402 presented at the Annual Congress of the European Hematology Association 3
(Date:9/12/2014)... attack from a pathogen, they sometimes respond by killing ... committing "cell suicide" to thwart further damage from the ... microscopic, spots or lesions on the plant. , But ... the plant regulates this "spotty" defense mechanism because the ... North Carolina State University have identified a number of ...
(Date:9/12/2014)... of dendritic cells in human skin have assorted functions ... report researchers in the journal EMBO Molecular Medicine ... the composition of dendritic cells in psoriatic skin lesions ... the disease. , "We urgently need new ways ... to patients and reduce the incidence of known side ...
(Date:9/11/2014)... Northumberland and Durham" by Nathaniel John Winch is re-published ... an example of combining modern information technology together with ... and data re-use. This publication will be supporting ongoing ... be seen as a model for other regions in ... the meticulous detail of old books with the interconnectedness ...
Breaking Biology News(10 mins):Corn spots: Study finds important genes in defense response 2Dendritic cells affect onset and progress of psoriasis 2Re-publication of 'Flora of Northumberland and Durham' (1831): A dramatic account of change 2Re-publication of 'Flora of Northumberland and Durham' (1831): A dramatic account of change 3
... ecosystem below an Antarctic glacier and learned that it survived ... growth. Described in the April 17 issue of ... a pool of brine trapped below Taylor Glacier and next ... Priscu , co-author of the Science article. Priscu ...
... over, Y chromosome it,s time X got some ... chromosome associated with being female, University of California, Berkeley, ... history of the X chromosome is every bit as ... important clues to the origins and benefits of sexual ...
... Sven Enerbck, Professor at the Institute of Biomedicine at the ... scientists who published their results in The New England ... Enerbck and others show that adults use brown fat to ... new possibilities in treating overweight and obesity. It has ...
Cached Biology News:Ancient ecosystem thrives millions of years below Antarctic glacier 2The story of X -- evolution of a sex chromosome 2The story of X -- evolution of a sex chromosome 3The story of X -- evolution of a sex chromosome 4
...
... Lyophilized. Lyophilized from 2 mM sodium ... human liver. Cathepsin D is a major ... as a 52 kDa proenzyme. Overexpression of ... associated with higher risk of relapse and ...
... Grade Thrombin is a highly purified preparation ... with appropriate vectors. The preparation is functionally ... is free of detectable contaminating proteases. Prepared ... by certified tests to be negative for ...
Rat Hepatocytes (RH) (>3,000,000 cells)...
Biology Products: